Table 1.
Sociodemographic and clinical characteristics of non-transplanted and PLT pwCF.
| Sociodemographic and clinical characteristics |
Non-transplanted patients (N = 5,074) |
PLT patients (post-transplant period of follow-up) (N = 1,006) |
|---|---|---|
| Female | 2,405 (47.4%) | 518 (51.5%) |
| Time of follow-up (in year) | ||
| Mean (std) | 10.8 (2.5) | 5.4 (4.0) |
| Median (Q1–Q3) | 12.0 (11.6–12.0) | 4.8 (1.9–8.6) |
| Age at the end of follow-up (in year) | ||
| 0–8 | 662 (13.0%) | 0 (0%) |
| 9–14 | 955 (18.8%) | 10 (1.0%) |
| 15–19 | 774 (15.3%) | 62 (6.2%) |
| 20–24 | 692 (13.6%) | 100 (9.9%) |
| 25–29 | 637 (12.6%) | 191 (19.0%) |
| 30–34 | 468 (9.2%) | 215 (21.4%) |
| 35–39 | 333 (6.6%) | 158 (15.7%) |
| 40–45 | 236 (4.7%) | 142 (14.1%) |
| >45 | 317 (6.2%) | 128 (12.7%) |
| Age at the end of follow-up (in year) | ||
| Mean (std) | 22.6 (13.5) | 33.5 (9.9) |
| Median (Q1–Q3) | 20.0 (12.0–30.0) | 33.0 (26.0–40.0) |
| Min–Max | 0.0–87.0 | 10.0–65.0 |
| Age at the date of transplantation (in year) | ||
| 0–8 | – | 5 (0.5%) |
| 9–14 | – | 43 (4.3%) |
| 15–19 | – | 122 (12.1%) |
| 20–24 | – | 243 (24.2%) |
| 25–29 | – | 227 (22.6%) |
| 30–34 | – | 172 (17.1%) |
| 35–39 | – | 97 (9.6%) |
| 40–45 | – | 62 (6.2%) |
| >45 | – | 35 (3.5%) |
| Age at the date of transplantation (in year) | ||
| Mean (std) | – | 27.5 (8.9) |
| Median (Q1–Q3) | – | 26.0 (21.0–33.0) |
| Min–Max | – | 5.0–60.0 |
| Death | 176 (3.5%) | 266 (26.4%) |
| Comorbidities identified by hospitalization diagnosis or specific therapies | ||
| Diabetes | 1,188 (23.4%) | 922 (91.7%) |